PMID- 29247241 OWN - NLM STAT- MEDLINE DCOM- 20190709 LR - 20211204 IS - 2045-2322 (Electronic) IS - 2045-2322 (Linking) VI - 7 IP - 1 DP - 2017 Dec 15 TI - Beneficial effects of melittin on ovalbumin-induced atopic dermatitis in mouse. PG - 17679 LID - 10.1038/s41598-017-17873-2 [doi] LID - 17679 AB - Atopic dermatitis (AD) is an inflammatory skin disease characterized by intense pruritus and relapsable eczematous lesions. The hallmarks of AD are defects in the epidermal barrier and immunoglobulin E (IgE)-mediated sensitization to several environmental allergens, as well as an immune disorder mediated by an imbalance toward T-helper-2 response. Melittin, a major component of bee venom, has been studied in various inflammatory diseases. However, the beneficial effects of melittin on mouse with AD-like symptoms have not been explored. Therefore, we investigated the anti-allergic effects of melittin. AD was induced by ovalbumin (OVA) patch. After agent treatment, skin tissues and sera were extracted from the sacrificed mice were used to demonstrate the effects of melittin through various molecular biological methods. The results showed that OVA-induced skin thickening and inflammatory infiltration were decreased in the melittin-treated group. Melittin prevented OVA-induced filaggrin deficiency and imbalanced inflammatory mediators. Furthermore, melittin inhibited IL-4/IL-13-induced filaggrin downregulation through the blockade of STAT3 activation in human keratinocytes. In summary, this study has shown that melittin ameliorated OVA-induced AD-like symptoms from various perspectives. The findings of this study may be the first evidence of the anti-inflammatory effects of melittin on OVA-induced AD. FAU - Kim, Woon-Hae AU - Kim WH AUID- ORCID: 0000-0002-1536-5374 AD - Department of Pathology, College of Medicine, Catholic University of Daegu, Daegu, Korea. FAU - An, Hyun-Jin AU - An HJ AD - Department of Pathology, College of Medicine, Catholic University of Daegu, Daegu, Korea. FAU - Kim, Jung-Yeon AU - Kim JY AD - Department of Pathology, College of Medicine, Catholic University of Daegu, Daegu, Korea. FAU - Gwon, Mi-Gyeong AU - Gwon MG AD - Department of Pathology, College of Medicine, Catholic University of Daegu, Daegu, Korea. FAU - Gu, Hyemin AU - Gu H AD - Department of Pathology, College of Medicine, Catholic University of Daegu, Daegu, Korea. FAU - Jeon, Minji AU - Jeon M AD - Department of Pathology, College of Medicine, Catholic University of Daegu, Daegu, Korea. FAU - Sung, Woo Jung AU - Sung WJ AD - Department of Pathology, College of Medicine, Catholic University of Daegu, Daegu, Korea. FAU - Han, Sang Mi AU - Han SM AD - Department of Agricultural Biology, National Academy of Agricultural Science, Jeonju-si, Korea. FAU - Pak, Sok Cheon AU - Pak SC AD - School of Biomedical Sciences, Charles Sturt University, Bathurst, Australia. FAU - Kim, Min-Kyung AU - Kim MK AD - Department of Pathology, College of Medicine, Dongguk University, Gyeongju-si, Korea. FAU - Park, Kwan-Kyu AU - Park KK AUID- ORCID: 0000-0002-5317-750X AD - Department of Pathology, College of Medicine, Catholic University of Daegu, Daegu, Korea. kkpark@cu.ac.kr. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20171215 PL - England TA - Sci Rep JT - Scientific reports JID - 101563288 RN - 0 (Allergens) RN - 0 (FLG protein, human) RN - 0 (Filaggrin Proteins) RN - 0 (Interleukin-13) RN - 0 (STAT3 Transcription Factor) RN - 20449-79-0 (Melitten) RN - 37341-29-0 (Immunoglobulin E) RN - 9006-59-1 (Ovalbumin) SB - IM MH - Allergens/pharmacology MH - Animals MH - Cells, Cultured MH - Dermatitis, Atopic/*chemically induced/*drug therapy/metabolism MH - Disease Models, Animal MH - Female MH - Filaggrin Proteins MH - Immunoglobulin E/metabolism MH - Interleukin-13/metabolism MH - Keratinocytes/drug effects/metabolism MH - Melitten/*pharmacology MH - Mice MH - Mice, Inbred BALB C MH - Ovalbumin/*pharmacology MH - STAT3 Transcription Factor/metabolism MH - Skin/drug effects/metabolism PMC - PMC5732199 COIS- The authors declare that they have no competing interests. EDAT- 2017/12/17 06:00 MHDA- 2019/07/10 06:00 PMCR- 2017/12/15 CRDT- 2017/12/17 06:00 PHST- 2017/07/31 00:00 [received] PHST- 2017/12/01 00:00 [accepted] PHST- 2017/12/17 06:00 [entrez] PHST- 2017/12/17 06:00 [pubmed] PHST- 2019/07/10 06:00 [medline] PHST- 2017/12/15 00:00 [pmc-release] AID - 10.1038/s41598-017-17873-2 [pii] AID - 17873 [pii] AID - 10.1038/s41598-017-17873-2 [doi] PST - epublish SO - Sci Rep. 2017 Dec 15;7(1):17679. doi: 10.1038/s41598-017-17873-2.